Title:
EP-Compliant Lavender Oil for Pharmaceutical Applications:GMP Documentation Suite
Content:
Meeting European Pharmacopoeia 10.0 standards, Blue EyesBiotech’s medicinal lavender oil delivers quantified actives for evidence-basedformulations:
- Anxiolytic Drugs: 39-43% linalool (validated in stressbiomarker reduction)
- Topical Analgesics: Synergistic terpene profile withCOX-2 inhibition data
- Inhalation Solutions: Particulate matter <0.1% (USP<788> compliant)
GMP Manufacturing Protocols:
- Class D cleanroom bottling
- Validated sterilization filtration(0.22μm PTFE)
- ICH Q1D accelerated stability data (36months)
Regulatory Support Package:
- EP Certificate of Suitability (CEP)drafting
- IMPD modules for clinical trial materials
- Extractables/Leachables studies forinhalation devices
Request EP monograph gap analysis:[email protected]
Access pharmaceutical dossier:www.blueeyes-bio.com